American Journal of Biomedical Research
ISSN (Print): 2328-3947 ISSN (Online): 2328-3955 Website: http://www.sciepub.com/journal/ajbr Editor-in-chief: Hari K. Koul
Open Access
Journal Browser
Go
American Journal of Biomedical Research. 2013, 1(2), 25-27
DOI: 10.12691/ajbr-1-2-1
Open AccessCase Report

Low Unconguted Estriol Levels in the Maternal Quadruple-Marker Screen in a Fetus with Cornelia de Lange Syndrome and a Partial Deletion of the NIPBL Gene

Patrick L. Wilson, , Jean Ricci Goodman, Erica Cole, John J. Mulvihill, Ji-Yun Lee, Shibo Li and Andrew Wagner

Pub. Date: March 15, 2013

Cite this paper:
Patrick L. Wilson, Jean Ricci Goodman, Erica Cole, John J. Mulvihill, Ji-Yun Lee, Shibo Li and Andrew Wagner. Low Unconguted Estriol Levels in the Maternal Quadruple-Marker Screen in a Fetus with Cornelia de Lange Syndrome and a Partial Deletion of the NIPBL Gene. American Journal of Biomedical Research. 2013; 1(2):25-27. doi: 10.12691/ajbr-1-2-1

Abstract

Prenatal diagnosis of Cornelia de Lange syndrome (CDLs) is difficult due to non-specific ultrasound and biochemical findings, normal karyotype, and negative family history. Previous studies suggest that low first and second trimester levels of pregnancy associated plasma protein-A are an indicator for this genetically heterogeneous condition, low levels of this protein can be non-specific. Here, we suggest the addition of estriol to the prenatal evaluation of CdLs. This steroid hormone, produced by the placenta from fetal 16-hydroxydehydroepiandrosterone, can serve as an indicator for fetal distress, placental dysfunction, and intrauterine growth retardation which is a feature of CdLs.

Keywords:
Cornelia de Lange Syndrome prenatal quadruple screen trisomy 18 microarray Smith Lemli Opitz syndrome placenta

Creative CommonsThis work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

Figures

Figure of 1

References:

[1]  Gillis, L.A., McCallum, J., Kaur, M., DeScipio, C., Yaeger, D., Mariani, A., Kline, A.D., Li, H.H., Devoto, M., Jackson, L.G., and Krantz I.D, “NIPBL mutational analysis in 120 individuals with Cornelia de Lange syndrome and evaluation of genotype-phenotype correlations,” American Journal of Human Genetics, 75 (4). 610-23. Oct.2004.
 
[2]  Lalatta, F., Russo, S., Gentilin, B., Spaccini, L., Boschetto, C., Cavalleri, F., Masciadri, M., Gervasini, C., Bentivegna, A., Castronovo, P., and Larizza, L, “Prenatal/neonatal pathology in two cases of Cornelia de Lange syndrome harboring novel mutations of NIPBL,” Genetics in Medicine, 9 (3). 188-94. Mar.2007.
 
[3]  Westergaard, J.G., Chemnitz, J., Teisner, B., Poulsen, H.K., Ipsen, L., Beck, B., and Grudzinskas, J,G, “Pregnancy-associated plasma protein A: a possible marker in the classification and prenatal diagnosis of Cornelia de Lange syndrome,” Prenatal Diagnosis, 3(3). 225-32. Jul.1983.
 
[4]  Aitken, D.A., Ireland, M., Berry, E., Crossley, J.A., Macri, J.N., Burn, J., and Connor J,M, “Second-trimester pregnancy associated plasma protein-A levels are reduced in Cornelia de Lange syndrome pregnancies,” Prenatal Diagnosis, 19(8). 706-10. Aug.1999.
 
[5]  Arbuzova. S., Nikolenko. M., Krantz. D., Hallahan. T., and Macri, J, “Low first trimester pregnancy-associated plasma protein-A and Cornelia de Lange syndrome,” Prenatal Diagnosis, 23(10). 864. Oct.2003.
 
[6]  Driscoll, D.A. and Gross, S.J, “Screening for fetal aneuploidy and neural tube defects,” Genetics in Medicine, 11 (11). 818-21. Nov.2009.
 
[7]  Schleifer, R.A., Bradley, L.A., Richards, D.S., and Ponting, N.R, “Pregnancy outcome for women with very low levels of maternal serum unconjugated estriol on second-trimester screening,” American Journal of Obstetrics and Gynecology, 173(4) .1152-6. Oct.1995.
 
[8]  Kim, S.Y., Kim, S.K., Lee, J.S., Kim, I.K., and Lee, K, “The prediction of adverse pregnancy outcome using low unconjugated estriol in the second trimester of pregnancy without risk of Down’s syndrome,” Yonsei Medical Journal, 41(2). 226-9. Apr.2000.
 
[9]  Dugoff, L, Society For Maternal-Fetal Medicine, “First- and second-trimester maternal serum markers for aneuploidy and adverse obstetric outcomes,” Obstetrics and Gynecology, 115(5). 1052-61. May.2010.
 
[10]  Wenstrom, K.D,, Owen, J., Brumfield, C.G., Davis, R.O., Dubard, M., and Garcia T, “Significance of a false-positive trisomy 18 multiple-marker screening test,” Obstetrics and Gynecology, 90(6). 938-42. Dec.1997.